Abstract:Background: Human apolipoprotein E (apoE) exists in three major isoforms: apoE2, apoE3 and apoE4. In the brain, apoE is produced mostly by astrocytes and transports cholesterol to neurons via apoE receptors. Among the gene alleles encoding the three isoforms, the APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD), whereas APOE2 is protective. ApoE4 confers a gain of toxic function, a loss of neuroprotective function or a combination of both in AD pathogenesis. Given that therapeutic impacts of modulating apoE expression may be isoform-dependent, we sought to investigate the relationship between overexpressing apoE isoform and apoE-related functions in apoE-targeted replacement (TR) mice. Specifically, apoE isoform expression driven by the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter was built into an adeno-associated virus serotype 8 (AAV8) vector and injected into the ventricles of postnatal day 2 (P2) apoE3-TR or apoE4-TR mice. Upon confirmation of apoE isoform expression, effects on apoE lipidation and the levels of amyloid-β (Aβ) in the brain were assessed. Results: AAV8-GFAP-apoE isoforms were specifically expressed in astrocytes throughout all brain regions, which led to overall increased apoE levels in the brain. Viral mediated overexpression of apoE4 in the apoE4-TR background increased poorly-lipidated apoE lipoprotein particles and decreased apoE-associated cholesterol in apoE4-TR mice. Conversely, apoE2 overexpression in apoE4-TR mice enhanced apoE lipidation and associated cholesterol. Furthermore, overexpression of apoE4 elevated the levels of endogenous Aβ, whereas apoE2 overexpression trended to lower endogenous Aβ. Conclusions: Overexpression of apoE isoforms induces differential effects in the apoE4-TR background: apoE4 decreases apoE lipidation and enhances Aβ accumulation, whereas apoE2 has the opposite effects. Our findings suggest that increasing apoE2 in APOE4 carriers is a beneficial strategy to treat AD, whereas increasing apoE4 in APOE4 carriers is likely harmful. We have also established novel methods to express apoE isoforms in mouse brain to study apoE-related pathways in AD and related dementia.

A simple approach for human recombinant apolipoprotein E4 expression and purification

Apolipoprotein E expression and purification

Apolipoprotein E4 heterologous expression, purification under non-denaturing conditions, and effects on neuronal clonal cell lines

Prokaryotic Expression of Human Apolipoprotein E and Analyses of the Molecular Interaction Between ApoE and PrP Proteins in Vitro

High-efficient bacterial production of human ApoA-I amyloidogenic variants

Cloning and expression of apolipoprotein E3 and its variant apoE2 and apoE4

High yield of recombinant human Apolipoprotein A-I expressed in Pichia pastoris by using mixed-mode chromatography

Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice

Efficient purification of Apolipoprotein A1 (ApoA1) from plasma by HEA HyperCel™: An alternative approach

The structure of human apolipoprotein E2, E3 and E4 in solution 1. Tertiary and quaternary structure

A Biophysical Approach to the Identification of Novel ApoE Chemical Probes

Production and Analysis of Biological Properties of Recombinant Human Apolipoprotein A-I

Foam fractionation studies of recombinant human apolipoprotein A-I

Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer

Characterization of a human apolipoprotein a-I construct expressed in a bacterial system

A Simplified Proteomics LC-MRM-MS Assay for Determination of apoE Genotypes in Plasma Samples

Preparation and Incorporation of Probe-Labeled Apoa-I for Fluorescence Resonance Energy Transfer Studies of Rhdl.

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis

Expression and functional reconstitution of a recombinant antibody (Fab′) specific for human apolipoprotein B-100